Abiopharma

New Form 4 - Royalty Pharma plc Filed: 2025-06-30 AccNo: 0001802768-25-000075 Size: 4 KB

New Form 424B3 - Aditxt, Inc. Filed: 2025-06-30 AccNo: 0001213900-25-059728 Size: 363 KB

New Form S-3ASR - Trulieve Cannabis Corp. Filed: 2025-06-30 AccNo: 0001628280-25-033530 Size: 1 MB

New Form 4 - ZEVRA THERAPEUTICS, INC. Filed: 2025-06-30 AccNo: 0001437749-25-021577 Size: 5 KB

New Form 4 - NATIONAL HEALTHCARE CORP Filed: 2025-06-30 AccNo: 0001437749-25-021575 Size: 12 KB

New Form 4 - Lexeo Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001415889-25-018523 Size: 5 KB

New Form 4 - Lexeo Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001415889-25-018524 Size: 5 KB

New Form 8-K - TuHURA Biosciences, Inc./NV Filed: 2025-06-30 AccNo: 0000950170-25-091693 Size: 229 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 4 - Lexeo Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001415889-25-018518 Size: 5 KB

New Form 8-K - Innovative Eyewear Inc Filed: 2025-06-30 AccNo: 0001829126-25-004807 Size: 239 KB Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

New Form 4 - Lexeo Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001415889-25-018522 Size: 5 KB

New Form 4 - Lexeo Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001415889-25-018520 Size: 5 KB

New Form 4 - Lexeo Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001415889-25-018521 Size: 5 KB

New Form 4 - Lexeo Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001415889-25-018519 Size: 5 KB

Aptose Announces Deferral of Interest Payment